# Seqirus Vaccines Limited, Liverpool, United Kingdom – FDA Inspections

Source: https://www.keypedia.com/companies/seqirus-vaccines-limited/6ad0915f-2ffc-46ca-be22-7620c05657c7

> Inspection records and compliance data for Seqirus Vaccines Limited in Liverpool. 9 FDA inspections on record, 3 Form 483s, last inspected June 10, 2025.

---

## Details

- Name: Seqirus Vaccines Limited
- FEI Number: 3002806949
- Address Line 1: Gaskill Road, Liv
- City: Liverpool
- Country Name: United Kingdom
- Address: Gaskill Road, Liv, Liverpool, United Kingdom
- Country: United Kingdom

## Related Documents

- FDA Inspection 1278103 - Seqirus Vaccines Limited - 2025-06-10 — source: FDA, date: June 10, 2025
- FDA Inspection 1278103 - Seqirus Vaccines Limited - 2025-06-10 — classification: No Action Indicated (NAI), source: FDA, date: June 10, 2025
- [483 - Seqirus Vaccines Limited - 2023-05-26](https://www.keypedia.com/records/483/seqirus-vaccines-limited/1246a69e-2e98-4f4f-be19-fc25857b5e40) — source: FDA, date: May 26, 2023
- [FDA Inspection 1206283 - Seqirus Vaccines Limited - 2023-05-26](https://www.keypedia.com/records/fda_inspections/seqirus-vaccines-limited/5706e716-8e0d-474d-b006-75d777a6ef04) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 26, 2023
- [FDA Inspection 1101068 - Seqirus Vaccines Limited - 2019-06-28](https://www.keypedia.com/records/fda_inspections/seqirus-vaccines-limited/094aeeba-88ac-49ef-9851-6bfea5ab7508) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 28, 2019
- [FDA Inspection 1019950 - Seqirus Vaccines Limited - 2017-06-30](https://www.keypedia.com/records/fda_inspections/seqirus-vaccines-limited/c013bf07-0028-45f4-844d-94604c5839e2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 30, 2017
- FDA Inspection 932651 - Seqirus Vaccines Limited - 2015-06-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 11, 2015
- FDA Inspection 826556 - Seqirus Vaccines Limited - 2013-03-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 19, 2013
- FDA Inspection 720826 - Seqirus Vaccines Limited - 2011-03-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 18, 2011
- FDA Inspection 658787 - Seqirus Vaccines Limited - 2010-04-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 23, 2010
- FDA Inspection 592458 - Seqirus Vaccines Limited - 2009-05-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 29, 2009

## Related Companies

- [LFB Biomanufacturing](https://www.keypedia.com/companies/lfb-biomanufacturing/fe9a1c8e-3f52-44a3-8a15-d4b93ffe8fbd)
- [Iovance Biotherapeutics Manufacturing LLC](https://www.keypedia.com/companies/iovance-biotherapeutics-manufacturing-llc/59bd3a38-6f16-456b-ab03-ec9b69306bed)
- [Oxford Biomedica (UK) Limited](https://www.keypedia.com/companies/oxford-biomedica-uk-limited/12d29c20-d7d1-4ab9-830f-5d9f25a506ad)
- [Octapharma S.A.S.](https://www.keypedia.com/companies/octapharma-sas/8e602de5-b511-4b74-aa10-2b4d1ef83dd5)
- [LFB USA, Inc.](https://www.keypedia.com/companies/lfb-usa-inc/0ce33194-ad37-4a33-ac26-fb8a40ba3c7c)
- [SmartPractice Denmark ApS](https://www.keypedia.com/companies/smartpractice-denmark-aps/e2173ee1-5bc6-4adb-af29-e5c541994c7e)
- [Baxalta Manufacturing Sarl](https://www.keypedia.com/companies/baxalta-manufacturing-sarl/71d79fb0-4c45-4139-b2d0-a6e38551344e)
- [Baxalta US Incorporated](https://www.keypedia.com/companies/baxalta-us-incorporated/bb2b5b07-7c9c-4fce-b969-4dc5fa402b64)
- [Merck Sharp & Dohme LLC](https://www.keypedia.com/companies/merck-sharp-dohme-llc/967df80c-3ba2-42c7-918c-af2c89dc721c)
- [Aldevron](https://www.keypedia.com/companies/aldevron/bced83de-adb4-45bc-8515-3bc205c76ec7)

## Related Officers

- [Lewis K. Antwi](https://www.keypedia.com/people/lewis-k-antwi/8ab4f1c7-8b5b-4556-98a4-6edc3bc49470)
- [investigator](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)
